Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus
Status:
Completed
Trial end date:
2020-08-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish preliminary evidence of the efficacy, safety, and
tolerability of LB1148 for the treatment of return of gastrointestinal function and decrease
Post-Operative Ileus in subjects undergoing elective bowel resection.